«Our structures of the complexes of the circadian clock proteins of cyanobacteria provided
important mechanistic insights, but are static snapshots of a system that's continuously moving and changing hour by hour,» said LiWang.
«The data presented at AACR provide
important new models and
mechanistic insights that inform our planned development efforts to evaluate the ability of microbiome therapy to augment immune checkpoint inhibitors,» said David Cook, Ph.D., Chief Scientific Officer and Executive Vice President of Research at Seres.